retatrutide clinical trial saudi arabia trials This data from Phase 3 clinical trials for Retatrutide was announced New Phase 3 retatrutide data

Obesity and the kidney: mechanistic links and therapeutic advances

While ashwagandha is not directly related to GLP-1 nutrient depletion, weight loss journeys are inherently stressful, and cortisol management can affect everything from sleep quality to insomnia patterns that many GLP-1 users report

Jackie's Take: What's on My Mind in Women's Wellness Thinking about microdosing a GLP-1

WEDNESDAY, June 10, 2026 (HealthDay News) -- For adults with type 2 diabetes (T2D) that is inadequately controlled with diet and exercise alone, retatrutide, a triple hormone receptor agonist, is associated with significant improvements in glycemic control and body weight reductions, according to a study published online June 6 in The Lancet to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.Harpreet S